INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $33,364 | +31.6% | 158,500 | 0.0% | 0.00% | +33.3% |
Q1 2023 | $25,360 | -71.2% | 158,500 | 0.0% | 0.00% | -72.7% |
Q4 2022 | $87,968 | -73.3% | 158,500 | +8.4% | 0.01% | -77.1% |
Q4 2021 | $329,000 | -34.2% | 146,200 | 0.0% | 0.05% | -42.2% |
Q3 2021 | $500,000 | +37.4% | 146,200 | +20.0% | 0.08% | +31.7% |
Q2 2021 | $364,000 | +134.8% | 121,800 | +66.4% | 0.06% | +96.9% |
Q4 2020 | $155,000 | – | 73,200 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
Bleichroeder LP | 250,000 | $298,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |